Jan Lauritzen Hoyt
Nurse Practitioner · Kingston, NYNPI 1114073582
Payments from drug & device makers
Across 332 payments — averaging $27.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$1K
- AstraZeneca$938
- GSK$841
- Lilly USA, LLC$738
- Johnson & Johnson$578
- plus $3K from 29 others
What the payments were for
- Food & beverage$9,103100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $1,797 |
| Novo Nordisk | 41 | $1,243 |
| AstraZeneca | 35 | $938 |
| GSK | 34 | $841 |
| Lilly USA, LLC | 30 | $738 |
| Johnson & Johnson | 14 | $578 |
| Pfizer | 27 | $574 |
| Amgen(2 entities) | 10 | $389 |
| Bayer | 6 | $200 |
| Axsome Therapeutics, Inc. | 3 | $196 |
| E.r. Squibb & Sons, L.L.C. | 2 | $141 |
| Boehringer Ingelheim | 8 | $140 |
| Amneal Pharmaceuticals LLC | 6 | $120 |
| Phathom Pharmaceuticals, Inc. | 1 | $118 |
| Merck | 7 | $106 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $104 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $96 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $94 |
| Astellas Pharma US Inc | 4 | $88 |
| Biohaven Pharmaceuticals, Inc. | 5 | $84 |
| Biogen | 2 | $83 |
| Novartis | 5 | $81 |
| Currax Pharmaceuticals LLC | 5 | $68 |
| Eisai Inc. | 2 | $44 |
| Abbott | 2 | $37 |
| Averitas Pharma Inc. | 1 | $29 |
| Medtronic | 1 | $25 |
| Alkermes, Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,103 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 69 | $63,257 |
| MounjaroTirzepatide | 35 | $36,500 |
| EliquisApixaban | 16 | $27,255 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $25,442 |
| SynthroidLevothyroxine Sodium | 36 | $2,823 |
| Rosuvastatin Calcium | 106 | $2,697 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 143 | $2,600 |
| Levothyroxine Sodium | 171 | $2,564 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 88 | $2,272 |
| Gabapentin | 85 | $1,989 |
| Atorvastatin Calcium | 151 | $1,776 |
| Diclofenac Sodium | 21 | $1,721 |
| Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide | 70 | $1,568 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $1,564 |
| Ezetimibe | 23 | $1,534 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $938 | $63,25769 claims |
| Lilly USA, LLCMounjaro | $738 | $36,50035 claims |
| PfizerEliquis | $574 | $27,25516 claims |
| GSKTrelegy Ellipta | $841 | $25,44232 claims |
| AbbVieSynthroid | $1,797 | $2,82336 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $120 | $2,564171 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $19 | $97423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,112 nurse practitioner providers in New York.
Other nurse practitioner in Kingston
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Kerry AhernEast Syracuse$55K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
- Carla JungquistCanandaigua$28K
- Kelly WilmarthJohnson City$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.